News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cancer Biotech Loxo Oncology Sets Terms For $57 Million IPO



7/22/2014 7:21:13 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Loxo Oncology, a biotech developing small molecule therapeutics to treat solid tumors, announced terms for its IPO on Monday. The Stamford, CT-based company plans to raise $57 million by offering 4.4 million shares at a price range of $12 to $14. At the midpoint of the proposed range, it would command a fully diluted market value of $211 million.

Help employers find you! Check out all the jobs and post your resume.

Read at Nasdaq


comments powered by Disqus
Nasdaq
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES